Qlucore announces major new release for bioinformatics Version 3.8 of Qlucore Omics Explorer enables faster and improved data visualizations. Qlucore, leading software provider of powerful visualization-based bioinformatics data analysis tools, announces Qlucore Omics Explorer (QOE) version 3.8, with new features ...
Read More »Twist Bioscience expands offering of synthetic SARS-CoV-2 RNA controls for NGS diagnostics
Twist announced the addition of four new synthetic SARS-CoV-2 RNA Controls for the development, verification, and ongoing validation of diagnostic tests. The controls include new variants of SARS-CoV-2, the virus that causes COVID-19...
Read More »Expanding the boundaries of RNA sequencing as a diagnostic tool for rare mendelian disease
Gene-panel and whole-exome analyses are now standard methodologies for mutation detection in Mendelian disease. However, the diagnostic yield achieved is at best 50%, leaving the genetic basis for disease unsolved in many individuals...
Read More »New RNA-Seq workflow taps thermostable group II intron reverse transcriptases for sequencing of human plasma RNA
Next-generation RNA-sequencing (RNA-seq) has revolutionized transcriptome profiling, gene expression analysis, and RNA-based diagnostics. Here, researchers at the University of Texas have developed a new RNA-seq method that exploits thermostable group II intron reverse transcriptases (TGIRTs) and used it to profile ...
Read More »Custom bioinformatics algorithm mines RNA-Seq data to identify transcripts that distinguish ovarian cancer cells from normal cells and provide new therapeutic targets
Ovarian cancer is notoriously difficult to diagnose and treat, making it an especially fatal disease. Researchers at University of California, San Diego School of Medicine and Moores Cancer Center have now identified six mRNA isoforms (bits of genetic material) produced ...
Read More »Next Generation Sequencing (NGS) Market by Platforms, Bioinformatics, Technology & by Application
NEW YORK, March 9, 2015 /PRNewswire/ — The global next generation sequencing market is dynamic and witnessing many changes with new products being introduced. The global NGS market will be worth $2.5 billion in 2014 and is poised to reach ...
Read More »